New inhaler tested for COPD breathing improvement
NCT ID NCT06110403
Summary
This study is testing how an inhaled medication called BGF 160 affects breathing patterns in people with stable COPD. Researchers will measure changes in how patients breathe and their lung function after using the medication. The study involves 35 participants aged 40-75 with moderate to severe COPD who experience significant breathing difficulties.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Lille
RECRUITINGLille, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.